Evaluation of the Role of Human Papillomavirus Testing and p16 Expression in the Management of Patients Undergoing Cervical Cancer Screening
- 18 years and older
- Ability to speak and clearly understand English
- Female patients
- No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.)
- Women who have had Pap smears within the previous 10 months
- Women under the age of 18.
- Women who are pregnant.
- Inability to give informed consent in English
Type of Study:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To provide cervical cancer screening (Pap smear, HPV test and/or p16 tests) to determine whether further intervention (colposcopy) is required
Outcome Time Frame:
1st visit, 12 months, 18 months follow up
Joan K Murphy, MD,FRCSC
University Health Network, Toronto
Canada: Canadian Institutes of Health Research
Pap Smear Study
- Cervical Cancer
- Pap test
- Healthy patients screened for cervical cancer tests.
- Uterine Cervical Neoplasms